Advances in genomics and cancer biology will alter the design of human cancer studies.
Advertisement
Critic At Large
Most Recent
Twenty-first century lab reports will include test results read by a new breed of pathologist.
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.
Twenty-first century challenges to the public health of all the world’s populations require forward-looking commitments from epidemiologists.
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
The path to eradicating malaria in Africa involves much more than just a vaccine.
Subjects
- culture
- disease/medicine
- funding
- opinion
- policy
- public health
- regulation
- science policy
- science publishing
- techniques
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
